Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
The cannabis sector is dealing with two notable scandals that is impacting the industry as a whole, CNBC's Jim Cramer said during his daily "Mad Money" show Wednesday.
Investors should be selective in their exposure to the space and be prepared to gradually buy best-of-breed names on the way down, the CNBC host said.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
What Happened
The first of two recent scandals is CannTrust Holdings Inc (NYSE:CTST), which was caught manufacturing cannabis in unlicensed rooms, Cramer said.
The other is Curaleaf Holdings Inc (OTC:CURLF), which was warned by the FDA to remove certain language from its website and social media accounts that contained unsubstantiated treatment claims.
Benzinga's Cannabis Capital Conference heads to Detroit on Aug. 15 — click here to learn more!
Why It's Important
CannTrust's stock rose from less than $2 in August 2017 to north of $10 by October 2018, as investors were attracted to lofty growth expectations.
Want Private Access to Benzinga Analyst?
Check out the latest strategies our team of experts are using every week so that you can always adapt to the market like the pros!—Get FULL Access to This Week's Webinar Here.
CannTrust was expected to produce as much as 300,000 kilos of cannabis by the end of 2020, but is instead are grappling with a scandal that "keeps blowing up," Cramer said.
Curaleaf's stock nearly tripled in value from late 2018 to April 2019 and, much like CannTrust, investors are experiencing a scandal, Cramer said.
While the FDA made it clear in its letter to Curaleaf that all it needs to do is "change how they label" certain items, it is now evident the regulatory body is "starting to flex its muscles against cannabis," he said.
Investors no longer care about growth stories and are for the first time prioritizing "actual results," Cramer said.
What's Next
Investors should stay away from companies that only offer investors "vague plans" or are losing a lot of money, Cramer said.
Instead, he said they should focus on well-capitalized leaders like Canopy Growth Corp (NYSE:CGC) and Cronos Group Inc (NASDAQ:CRON).
These two stocks are long-term plays, and investors should be "prepared to buy them gradually on the way down," he said.
Curaleaf shares were down 0.86% at the time of publication Thursday, while CannTrust shares were down 3.4%.
Don’t miss out on the top cannabis stories of the day. Click here to sign up for our daily insider newsletter.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.